Company intelligence / Profile preview

ARJIL Pharmaceuticals

Taiwan Province of Chinaarjilpharma.com ↗
Ownership
Private
Development stage
Clinical
01

Overview

ARJIL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in Taiwan in 2014. It develops innovative botanical-based medicines and small molecules targeting age-related conditions and immune/inflammatory disorders. Its lead program AR‑100 has reached Phase I/II trials for atopic dermatitis; other pipeline assets remain preclinical or earlier.[6][3] The company has raised over $8 million USD in funding as of early 2024.[6] No commercialized products yet.

Therapeutic areas
GastroenterologyCardiovascularRheumatologyImmunologyDermatologyNeurologyInfectious Diseases
Modalities
Botanical-based medicines (herbal medicines)Small molecule drugsBiological productsAptamers[6][1][3]
Industry
Biotech
02

Partnerships

No major pharmaceutical partnerships disclosed publicly. Some licensing from Industrial Technology Research Institute noted for lead asset originator.[3]

Beyond the preview

Go deeper on ARJIL Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARJIL Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call